Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chisesi

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|April 27, 2004
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study GroupG Santini, C De Souza, S Aversa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2005
Meta-analysis to evaluate the role of interferon in follicular lymphomaA Z S Rohatiner, W M Gregory, B Peterson, et al.
Haematologica|March 20, 2001
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphomaG Santini, S Nati, M Spriano, et al.
Blood|January 29, 2000
Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano LinfomiM Federico, U Vitolo, P L Zinzani, et al.
Haematologica|February 22, 2000
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study GroupG Santini, P Coser, A M Congiu, et al.
Leukemia & Lymphoma|May 7, 1998
Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvementG Santini, A M Congiu, S Nati, et al.
Leukemia|June 1, 1996
Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvementG Santini, A M Congiu, S Nati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2005
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSGA Olivieri, G Santini, C Patti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study GroupG Santini, L Salvagno, P Leoni, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|April 27, 2004
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study GroupG Santini, C De Souza, S Aversa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2005
Meta-analysis to evaluate the role of interferon in follicular lymphomaA Z S Rohatiner, W M Gregory, B Peterson, et al.
Haematologica|March 20, 2001
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphomaG Santini, S Nati, M Spriano, et al.
Blood|January 29, 2000
Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano LinfomiM Federico, U Vitolo, P L Zinzani, et al.
Haematologica|February 22, 2000
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study GroupG Santini, P Coser, A M Congiu, et al.
Leukemia & Lymphoma|May 7, 1998
Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvementG Santini, A M Congiu, S Nati, et al.
Leukemia|June 1, 1996
Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvementG Santini, A M Congiu, S Nati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2005
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSGA Olivieri, G Santini, C Patti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study GroupG Santini, L Salvagno, P Leoni, et al.
Pageof 9